Gagnon Securities’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
– Sell
-10,692
Closed -$226K – 90
2017
Q1
$226K Buy
+10,692
New +$209K 0.1% 83
2015
Q3
– Sell
-12,144
Closed -$243K – 88
2015
Q2
$243K Sell
12,144
-3,500
-22% -$61.5K 0.1% 72
2015
Q1
$244K Buy
15,644
+20
+0.1% +$302 0.08% 76
2014
Q4
$215K Buy
+15,624
New +$191K 0.07% 79

Other funds holding DXCM

Gagnon Securities's DXCM Position: Q2 2017 in Review

Gagnon Securities sold out of DexCom (DXCM) in Q2 2017, closing a stake of 10,692 shares — an estimated $226K sold.

Gagnon Securities first reported a position in DXCM in Q4 2014 and held it in 4 quarters. The position peaked at $244K in Q1 2015. 311 funds tracked by Wall St. Rank hold DXCM as of Q2 2017.

  • Gagnon Securities reported no remaining DexCom position as of Q2 2017 after selling out during the quarter.
  • Gagnon Securities sold 10,692 DexCom shares in Q2 2017, an estimated $226K.
  • Gagnon Securities first reported a position in DexCom in Q4 2014 and held it in 4 quarters.
  • Gagnon Securities's DexCom position peaked at $244K in Q1 2015.
  • 311 funds tracked by Wall St. Rank held DexCom as of Q2 2017.

Based on Gagnon Securities's 13F filing for Q2 2017, filed 20 Jul 2017.